Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      • Home
      • Farhat Nasim

      Articles By : Farhat Nasim

      Novartis gets USFDA nod for over Rs 13 crore gene therapy Zolgensma

      Novartis gets USFDA nod for over Rs 13 crore gene therapy Zolgensma

      Farhat Nasim25 May 2019 10:00 AM IST
      The Food and Drug Administration on Friday approved the treatment, called Zolgensma, for all children under age 2 who are confirmed by a genetic test...
      JnJ loses talc verdict in New York; to pay over Rs 174 crore: Bloomberg

      JnJ loses talc verdict in New York; to pay over Rs 174 crore: Bloomberg

      Farhat Nasim24 May 2019 11:36 AM IST
      JnJ faces more than 14,000 claims that its powders caused ovarian cancer and mesothelioma, rare cancer linked to asbestos exposure.New Delhi: Johnson...
      GSK reintroduce incentives for sales representatives

      GSK reintroduce incentives for sales representatives

      Farhat Nasim24 May 2019 9:31 AM IST
      GSK said it would make changes to its incentive program for pharmaceutical and vaccines sales representatives, to be applied initially in the United...
      Zydus Cadila gets USFDA approval for Esomeprazole Magnesium delayed-release capsules

      Zydus Cadila gets USFDA approval for Esomeprazole Magnesium delayed-release capsules

      Farhat Nasim23 May 2019 12:15 PM IST
      The company said Esomeprazole belongs to the group of medicines termed as proton pump inhibitors.New Delhi: Zydus Cadila has received final approval...
      Biocon, Mylan gets Canadian nod for biosimilar of cancer drug Herceptin

      Biocon, Mylan gets Canadian nod for biosimilar of cancer drug Herceptin

      Farhat Nasim23 May 2019 11:59 AM IST
      Ogivri is the first trastuzumab biosimilar approved in Canada and the second biosimilar from Biocon and Mylan's joint portfolio approved in the...
      Lupin launches generic version of Pulmicort Respules Inhalation Suspension

      Lupin launches generic version of Pulmicort Respules Inhalation Suspension

      Farhat Nasim23 May 2019 9:30 AM IST
      Lupin's product is a generic version of AstraZeneca Pharmaceuticals LP's Pulmicort Respules Inhalation Suspension, 0.5 mg/2 mL.New Delhi: Drug maker...
      Medtronic says wont recall pacemakers in India; in discussion with CDSCO

      Medtronic says won't recall pacemakers in India; in discussion with CDSCO

      Farhat Nasim22 May 2019 11:57 AM IST
      Stressing that it was "not a case of product recall", Medtronic India said, "We are in proactive discussion with CDSCO".New Delhi: In contrast to the...
      Panacea Biotec gets USFDA nod for chemotherapy drug Azacitidine

      Panacea Biotec gets USFDA nod for chemotherapy drug Azacitidine

      Farhat Nasim22 May 2019 9:45 AM IST
      Azacitidine is a chemotherapy drug used to treat myelodysplastic syndromes (MDS) with annual sales of about USD 110 million in US markets as per IQVIA...
      Alembic Pharma gets USFDA nod for Solifenacin Succinate tablets to treat overactive bladder

      Alembic Pharma gets USFDA nod for Solifenacin Succinate tablets to treat overactive bladder

      Farhat Nasim22 May 2019 9:15 AM IST
      The company has received approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Solifenacin...
      Glenmark Pharma gets USFDA nod for generic version of Vesicare tablets

      Glenmark Pharma gets USFDA nod for generic version of Vesicare tablets

      Farhat Nasim21 May 2019 11:31 AM IST
      The approved product, Solifenacin Succinate tablet is a generic version of Vesicare tablets of Astellas Pharma US, Inc.New Delhi: Glenmark...
      CCI dismisses complaint against Cipla, chemist body over alleged non-supply of medicines

      CCI dismisses complaint against Cipla, chemist body over alleged non-supply of medicines

      Farhat Nasim21 May 2019 9:45 AM IST
      New Delhi: In a major relief to Mumbai based Cipla Ltd and Bengal Chemist and Druggists Association (BCDA), the Competition Commission of India has...
      JnJ largest India plant for cosmetics, baby products stand idle three years after completion

      JnJ largest India plant for cosmetics, baby products stand idle three years after completion

      Farhat Nasim20 May 2019 12:49 PM IST
      At the local pollution control board office, the member secretary Satyanarayana Reddy said the JnJ plant had all the required approvals and he was not...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok